Akebia Therapeutics Inc. (AKBA)

AKBA trades at $3.04, 21.6% above the near-term max pain of $2.5 expiring Sep 19, 2025 (31 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2-$2.5), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for AKBA shows a downward trend from 2.5 to 2, indicating bearish sentiment or hedging activity. The 21% spread signals divergent expectations across timeframes. Most levels below 3.04 may cap rallies. Strong magnetic level at 3 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.